The immune system is counted as an important variable in the process of cancer breakout, growth, metastasis and recurrence. Without the active immune system, even a negligible cancer cell that has survived after a surgery can grow into sizable cancer cells within a short period of time.
When significant immunosuppression is observed within a patient, chemotherapy or radiotherapy cannot be continued resulting in higher chances of metastasis or recurrence. Thus increasing immunity is essential in attempting reducing the chances of metastasis or recurrence.
Myun Yuk Dan (PSM), anti-cancer Myun Yuk syrup (HMSY), and Sojuk Baekchul San (SBS) of EWCC have proven in laboratory and clinical tests that by activating T and B lymphocyte, natural killer cell, and macrophage, we can further reduce chances for metastasis and recurrence.